SOX10 and melanoma: Of note, there are some metabolic alterations specific to oncogenic mutations or melanocytic lineage, including mutated BRAF-driven ketogenesis and SOX10-mediated SAMMSON upregulation and mitochondrial oxidative phosphorylation, which might provide an accessible target for a specific subgroup of patients with melanoma.